Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.91B |
| 2 |
United Parcel Service
UPS
|
+$1.86B |
| 3 |
Chevron
CVX
|
+$1.72B |
| 4 |
Blackstone
BX
|
+$904M |
| 5 |
Ford
F
|
+$722M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$1.64B |
| 2 |
Prudential Financial
PRU
|
+$553M |
| 3 |
Genuine Parts
GPC
|
+$543M |
| 4 |
Cummins
CMI
|
+$538M |
| 5 |
Hartford Financial Services
HIG
|
+$376M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.33% |
| 2 | Healthcare | 13.03% |
| 3 | Financials | 11.86% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Industrials | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Central Garden & Pet Co
CENT
$2.76B
| $3.55M | ﹤0.01% |
108,181
+15,102
| +16% | +$489K |
|
|
HA
2352
DELISTED
Hawaiian Holdings, Inc.
HA
| $3.55M | ﹤0.01% |
387,485
-173,322
| -31% | -$1.84M |
|
2353
VSE Corp
VSEC
$6.01B
| $3.54M | ﹤0.01% |
78,949
+436
| +0.6% | +$22.1K |
|
2354
Fate Therapeutics
FATE
$300M
| $3.53M | ﹤0.01% |
618,835
+4,202
| +0.7% | +$25.4K |
|
|
BORR
2355
Borr Drilling
BORR
$1.24B
| $3.48M | ﹤0.01% |
459,706
+4,790
| +1% | +$30.9K |
|
|
FARO
2356
DELISTED
Faro Technologies
FARO
| $3.47M | ﹤0.01% |
141,136
-189
| -0.1% | -$5.24K |
|
2357
The RMR Group
RMR
$325M
| $3.46M | ﹤0.01% |
132,019
+22,619
| +21% | +$634K |
|
2358
Xperi
XPER
$384M
| $3.46M | ﹤0.01% |
316,881
-144,460
| -31% | -$1.51M |
|
2359
Franklin Covey
FC
$244M
| $3.46M | ﹤0.01% |
90,020
+257
| +0.3% | +$11.9K |
|
2360
Coherus Oncology
CHRS
$228M
| $3.46M | ﹤0.01% |
505,242
-1,547
| -0.3% | -$12K |
|
2361
U-Haul Holding Co
UHAL
$14.4B
| $3.45M | ﹤0.01% |
57,814
-27,655
| -32% | -$1.74M |
|
2362
Ecopetrol
EC
$33.5B
| $3.45M | ﹤0.01% |
326,287
-15,695
| -5% | -$170K |
|
2363
nLIGHT
LASR
$4.35B
| $3.44M | ﹤0.01% |
338,030
+8,295
| +3% | +$95.5K |
|
2364
Midland States Bancorp
MSBI
$717M
| $3.44M | ﹤0.01% |
160,548
-2,061
| -1% | -$51.8K |
|
2365
IES Holdings
IESC
$15.1B
| $3.43M | ﹤0.01% |
79,579
-1,659
| -2% | -$68.1K |
|
2366
Xometry
XMTR
$5.06B
| $3.42M | ﹤0.01% |
228,477
-765
| -0.3% | -$20.1K |
|
2367
Nurix Therapeutics
NRIX
$2.56B
| $3.42M | ﹤0.01% |
384,840
+1,925
| +0.5% | +$20.1K |
|
2368
Alkami Technology
ALKT
$2.02B
| $3.42M | ﹤0.01% |
269,802
-1,690
| -0.6% | -$24.9K |
|
2369
NovaGold Resources
NG
$2.78B
| $3.39M | ﹤0.01% |
545,327
+6,173
| +1% | +$37.6K |
|
|
CYBR
2370
DELISTED
CyberArk
CYBR
| $3.37M | ﹤0.01% |
22,789
+484
| +2% | +$67.6K |
|
2371
Aurinia Pharmaceuticals
AUPH
$1.92B
| $3.35M | ﹤0.01% |
305,984
+5,269
| +2% | +$46.4K |
|
2372
Arcutis Biotherapeutics
ARQT
$3.26B
| $3.33M | ﹤0.01% |
302,502
+774
| +0.3% | +$11.2K |
|
|
CFB
2373
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $3.33M | ﹤0.01% |
317,299
-3,043
| -0.9% | -$38.9K |
|
2374
Aclaris Therapeutics
ACRS
$835M
| $3.32M | ﹤0.01% |
410,220
-1,913
| -0.5% | -$24.3K |
|
2375
Microvision
MVIS
$85.2M
| $3.3M | ﹤0.01% |
82,494
+690
| +0.8% | +$26.1K |
|
Similar funds
Charles Schwab's Q1 2023 Portfolio in Review
As of Q1 2023, Charles Schwab held 3,654 positions worth $329B, up 6% from $310B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q1 2023 filing shows 108 new, 2,088 increased, 988 reduced and 104 closed positions. Its largest new stake was GE HealthCare: 1,875,333 shares worth $154M. The largest sale was IBM, an estimated $1.64B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q1 2023 buy was GE HealthCare: 1,875,333 shares worth $154M.
- Charles Schwab added most to AbbVie in Q1 2023, an estimated $1.91B increase.
- Charles Schwab's biggest Q1 2023 reduction was IBM, cutting an estimated $1.64B.
- Charles Schwab fully exited STORE Capital Corporation in Q1 2023, selling an estimated $100M.
- Charles Schwab's ten largest holdings make up 17% of its $329B portfolio in Q1 2023.
- Charles Schwab opened 108 new positions and closed 104 in Q1 2023.
- Charles Schwab's portfolio value rose 6% quarter-over-quarter to $329B.
Based on Charles Schwab's 13F filing for Q1 2023, filed 12 May 2023.